Objective: This paper describes a process for ensuring and documenting Health Insurance Portability and Accountability Act (HIPAA) compliance in clinical practice-based research. Methods: The Center of Excellence for Research in Complementary and Alternative Medicine was funded by National Center for Complementary and Integrative Health to develop the methods for researching the appropriateness of care in complementary and integrative health, which previously was known as complementary and alternative medicine. We recruited 125 participating chiropractic clinics for enrolling patients and gathering their data via the online surveys. Chiropractic clinics completed the following: (1) obtained the files of patients who provided prior consent (the prospective sample), (2) obtained the files of the patients selected randomly using specified randomization procedures (the retrospective sample), and (3) transferred all patient data to the RAND Corporation via an encrypted file. Results: Most of the doctors of chiropractic from clinical practices had no concerns about obtaining and transferring the files of patients who provided informed consent. However, some doctors were uneasy about allowing the researchers to access the randomly selected files of patients who had not provided prior authorization. This led us to develop a set of forms to provide clinics about HIPAA compliance. Conclusion: For this study, we provided clinics with information about the rules under HIPAA, demonstrated how the study complied with those rules, explained the logic behind the necessity for collecting files from both the prospective and retrospective samples, and, if requested, provided clinics with a confidentiality agreement signed by the study principal investigator and an organizational contracts representative. The process we developed may assist other complementary and integrative health researchers and practitioners in future studies. (2018;41:807-813) 
INTRODUCTION
As the landscape of health care delivery and data security in the United States becomes more complex, health care practitioners and their staff must be increasingly knowledgeable about which activities are allowable under the Health Insurance Portability and Accountability Act (HIPAA). Created by U.S. legislators in 1996, HIPAA outlines data privacy and security provisions for safeguarding medical information. 1 The Act balances the following 2 objectives: (1) the safety and protection of patient health records and (2) the accessibility of such records as necessary to those providing care.
All health care providers and their clinic staff must be HIPAA compliant. Most state associations, including those of doctors of chiropractic and physical therapists, offer courses and presentations to educate their professions about their legal HIPAA responsibilities. Numerous outside organizations offer a variety of online and offline education modules that are also accessible. 2 Because compliance is a legal obligation, many practitioners and their office managers and staff are rightly concerned about the protection of patient data. However, this can have a chilling effect on practice-based research. It is our experience that while the profession is literate about the HIPAA regulations, they are less educated about the rules regarding research under HIPAA. This lack of knowledge can severely hinder research studies because it increases the difficulty of obtaining data needed to complete such endeavors.
The focus on practice-based primary data collection is beneficial to health care, including complementary and integrative health (CIH; previously known as complementary and alternative medicine), chiropractic, and other professions, for several reasons. First, it re-centers the role of the clinical practice in evidence-based research and increases the likelihood that research focuses more on actual holistic care instead of just modalities such as manipulation or manual therapy. Further, this relationship is more likely to promote comparative effectiveness research, which has advantages for the professions compared with traditional randomized controlled trials. 3 Given these factors, practice-based primary data collection, which often occurs through the extraction of data from patient charts, will constitute an important source of research data for the chiropractic and physical therapy communities.
The purpose of this paper is to describe the processes we have developed during our research efforts to address these issues. In this paper, we draw on our research project on chiropractic manipulation and mobilization for chronic low back pain and chronic neck pain to explore this issue and to share the solutions we have used. We provide suggestions for other researchers in the United States who want to collect data from chiropractic clinics and similar settings in the United States. Hopefully, the information will also be helpful to practitioners and their staffs as they negotiate the landscape of HIPAA.
Research Under HIPAA in the United States
Chiropractic and other manipulative and manual care is still largely conducted in independent clinical practices and may not be covered in many insurance schemes. Also, the clinical practices are still a mixture of paper and electronic records. In this study, 4 ,5 23% of the clinics had only electronic records, 32% only paper, and 45% a combination. This limits the ability to use large pre-existing electronic and insurance datasets for research. Therefore, for the foreseeable future, much of manual and manipulative research will involve primary data collection from clinical practices with a mixture of record types.
The process of using patient files for research is not an issue when the patient provides informed consent for such access. This consent is distinct from their consent to treat, which they must give. The difficulty arises when the researchers wish to access patient files without first obtaining informed consent.
One may ask why the researchers do not just obtain the patients' consent to use their files. In many cases this is simply not possible, not practical, or not cost-effective. In these instances, insisting on patient consent might in fact mean the study cannot be done. The task of obtaining the random sample and then approaching all the patients who are included is quite costly because it may require multiple visits to a clinic and considerable time to obtain the consent. When it is not possible, not practical, or not cost-effective to obtain patient consent, conducting research on randomly selected patient files without their prior authorization is difficult. Another example of the logistical problems is if a researcher wanted to access a random sample of all the treatments that doctors of chiropractic have submitted under Medicare. 4 It would be logistically impossible to obtain patient consent because of the magnitude of the task. Furthermore, given that the files in the sample are randomly selected, the research cannot predetermine which files are to be included and thus cannot obtain patient consent before drawing the sample. However, because such research is imperative to understanding various aspects of patient care, a set of rules has been devised to allow it.
There are rules that allow researchers to obtain patient files without informed consent and without violating HIPAA. The following section will describe the study currently in progress at the RAND Corporation that collected patient files from chiropractic clinics in a manner adherent to these regulations.
THE STUDY
In 2014, RAND was funded by the National Center for Complementary and Integrative Health to create a Center of Excellence for Research in Complementary and Alternative Medicine. It was not a clinical trial but was registered as an observational study on ClinicalTrials.gov ID: NCT03162952. The study has been described previously in the literature. 4 ,5 Specifically, we were to investigate the appropriateness of manipulation and mobilization for chronic low back and neck pain. At over $8 million, this is one of the largest studies ever funded by the National Institutes of Health to study chiropractic care.
Given the huge concern about the opioid epidemic in the United States, 6 ,7 the execution of this project is quite timely. There is currently a huge interest in the United States in nonpharmacological alternatives for pain treatment, and chronic back and neck pain are 2 of the most prevalent forms of pain. As such, the chiropractic profession may be strategically placed to provide such care. However, to do so may require the profession to produce data to answer following questions:
1. How much chronic low back and neck pain do chiropractors treat? 2. What are the treatments delivered? 3. How much of said treatment is appropriate? 4. What outcomes do patients derive from this care? 5. What are the costs of the treatment to the patients or insurance companies?
To date, there exists very little information and even less data to answer these questions. The RAND chiropractic study was designed to provide the answers.
Although a full description of the study is beyond this article, 5 addressing these questions required that we recruit chiropractic clinics across the United States using a systematic stratified cluster sample (New York, Minnesota, Oregon, Texas, Florida, California), and in those clinics, we did 2 things. We enrolled a prospective sample of patients with chronic back and neck pain and followed them over 3 months to record their outcomes, preferences, and costs associated with chiropractic care. All patients in this prospective sample were recruited in chiropractic clinics using web-enabled tablets, then consented, enrolled, and followed in the study via online surveys. Using this method, we recruited 2024 patients, 83% of whom completed the final 3-month survey. Of those recruited, 92% signed a consent to also release their patient files to the research team so that we could abstract information from those files. For the second part of the study, we drew a random sample of files from each clinic's chronic back and neck pain patient population to examine the care received by these individuals. Combined, obtaining the files of the patients who completed the online surveys (prospective sample) and the files of the randomly selected patients (retrospective sample) was termed the "chart pull" portion of the study. In total, around 80% of the clinics participated in the chart pulls. From those, we had 1,477 charts from patients who participated in the study and 2,116 carts obtained randomly.
THE PROBLEM
Most of the 125 participating chiropractic clinics had no problem with our methods for enrolling patients and gathering their data via the online surveys. For the chart pull portion of the study, which occurred after the web survey data collection period ended, participating chiropractic clinics had to do the following: (1) obtain the files of patients who provided prior consent (the prospective sample), (2) obtain the files of the patients randomly selected using specified randomization procedures (the retrospective sample), and (3) transfer all patient data to RAND via an encrypted file. To assist with this process, we offered to either send a RAND study team to the clinic and work with staff to obtain and transfer all requested patient files or train clinic staff (via either in-person visit or phone call) and provide all necessary equipment for them to obtain and transfer the requested patient files.
Most of the participating clinical practices had no concerns about obtaining and transferring the files of patients who provided informed consent, but many were uneasy about allowing the study to access the randomly selected files of patients who had not provided any prior authorization. For some of the clinics, it caused some concern about the legality of obtaining the files. This was often raised by the officer manager or, in some instances, the legal advisor to the clinic. This then made us revisit the question of what do we need to provide to clinics to deal with this concern. But it also raised in our minds that this should perhaps be a standard process for all clinics we approach in future studies. The following section outlines the method used to allay concerns.
THE SOLUTION
Our approach to addressing concerns about sharing patient files focused on providing a review of the HIPAA rules, noting why sharing the data in these files was important and how the study complied with the rules. We also provided, if requested, a confidentiality agreement between the clinic and the study team that was signed by both the study's principal investigator and RAND's contracts office.
The Rules of HIPAA and Research
Under the HIPAA Privacy Rule, researchers can obtain and use individually identifiable health information given they follow the stipulations set forth in the legislation. Individually identifiable data is "information, including demographic data, that relates to: (1) the individual's past, present or future physical or mental health or condition, (2) the provision of health care to the individual, or (3) the past, present, or future payment for the provision of health care to the individual."
8 Individually identifiable information is called protected health information (PHI) when is it created or received by a "covered entity."
"Covered entities," defined as health care providers (such as doctors of chiropractic), health care plans, or health care clearinghouses, are permitted to disclose PHI, either with or without patient authorization, under a limited set of circumstances described in the HIPAA Privacy Rule. 9 To use or obtain PHI without prior authorization from the research participant, researchers must provide covered entities with "Documented Institutional Review Board (IRB) or Privacy Board Approval." 10 Regulatory IRBs can grant approval for a waiver of participants' authorization if the researchers were to "conduct records research, when researchers are unable to use de-identified information, and the research could not be practically conducted if research participants' authorization were required." 10 For the RAND Chiropractic Study for Chronic Pain, researchers first demonstrated to our organizational IRB that the work we planned to undertake for the chart pull portion of the study met each of these 3 criteria and then documented how we planned to satisfy the requirements necessary to obtain a waiver of patient authorization.
In Figure 1 , we provide details about how our study complied with each of those points.
Getting IRB Approval
We obtained approval from RAND's IRB, the Human Subjects Protection Committee (HSPC), for all aspects of data collection for this project, including collecting data from patient files at the chiropractic clinics. The approval for the overall project was an iterative process that involved submitting many amendments to the committee as we CondiƟon for waiving paƟent authorizaƟon How our study meets this condiƟon 1. The use or disclosure of protected health informaƟon involves no more than a minimal risk to the privacy of individuals, based on, at least, the presence of the following elements:
1a. an adequate plan to protect the idenƟfiers from improper use and disclosure:
In our data safeguarding plan (DSP), we detailed how we will protect idenƟfiers in the chart from improper use and disclosure. Further, we created a formal confidenƟality statement that the study Principal InvesƟgator and our organizaƟonal contracts representaƟve to be signed and provided to parƟcipaƟng clinics.
To adequately protect idenƟfiers from improper use and disclosure, we did the following:
For transfer of electronic files: -Used a secure server for transfer of all paƟent chart data -If there is no internet access in a clinic, used an encrypted hard drive that is transferred (sent) to the clinic using conƟnuously secured methods. Hard drive encrypƟon passwords were shared with clinic staff via only the phone or secure server. A master file of all passwords was stored at RAND using PGP encrypƟon For data storage: Data files were uploaded to a secure computer and stored in accordance with the organizaƟon's standards for Highly SensiƟve data on organizaƟonal devices.
Ensured our protocols were approved by the organizaƟon InformaƟon Security management officials.
1b. An adequate plan to destroy the idenƟfiers at the earliest opportunity consistent with the conduct of the research, unless there is a health or research jusƟficaƟon for retaining the idenƟfiers or such retenƟon is otherwise required by law; and Specified that the study would destroy all paƟent records using secure file delete soŌware delete three years' post-study compleƟon.
1c. Adequate wriƩen assurances that the protected health informaƟon will not be reused or disclosed to any other person or enƟty, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health informaƟon would be permiƩed by this subpart;
Created a formal ConfidenƟality Statement (see Appendix) that was signed and provided to any parƟcipaƟng clinics who requested it, and included provisions for how our study would use paƟent data. Further, all data abstractors were HIPAA trained on how to safeguard and handle paƟent data appropriately.
2. The research could not pracƟcably be conducted without the waiver or alteraƟon; and As aforemenƟoned, a random sample of charts from clinics is essenƟal to address the study's key research quesƟons, such as esƟmaƟng the amount of chronic low back and neck pain being treated at these clinics, and the amount of appropriate and inappropriate care.
While we obtained paƟent authorizaƟon to pull charts for the paƟent survey parƟcipants (i.e. the prospecƟve sample), it is not feasible to obtain such authorizaƟon from paƟents whose charts will be pulled at random (i.e. the retrospecƟve sample). We employed complex random sampling procedures in which charts were obtained and then screened to determine if they met the qualificaƟons for chronic pain. This process was repeated unƟl we met our target number of chronic pain charts from each clinic, and then these charts were transferred to RAND where they were later abstracted. Given this, it was not feasible to contact each paƟent within this process. Without reviewing their chart data to answer our screening quesƟons, we cannot know if the chart will be included and therefore would not know how many charts to review in total or how many paƟents to contact.
3. The research could not pracƟcably be conducted without access to and use of the protected health informaƟon.
Protected Health InformaƟon about paƟents' pain history and treatment is essenƟal to answering key research quesƟons about the amount of chronic low back and neck pain being treated at these clinics, the care they are receiving, and the amount of appropriate and inappropriate care. moved forward with the various components of our study and occasionally revising our protocols in response to feedback from our reviewers. However, we did receive full approval and the HSPC provided the study team a signed letter on institutional letterhead to confirm this and to explain why the committee decided that a waiver of HIPAA patient informed consent authorization for the retrospective random sample was appropriate.
For the IRB or privacy board to approve a waiver of authorization under the privacy rules, 3 criteria must be satisfied:
1. "The use or disclosure of protected health information involves no more than a minimal risk to the privacy of individuals, based on, at least, the presence of the following elements:
• an adequate plan to protect the identifiers from improper use and disclosure; • an adequate plan to destroy the identifiers at the earliest opportunity consistent with the conduct of the research, unless there is a health or research justification for retaining the identifiers or such retention is otherwise required by law; and • adequate written assurances that the protected health information will not be reused or disclosed to any other person or entity, except as required by law, for authorized oversight of the research project, or for other research for which the use or disclosure of protected health information would be permitted by this subpart;
2. The research could not practicably be conducted without the waiver or alteration; and 3. The research could not practicably be conducted without access to and use of the protected health information." 10 To release patient information without patient authorization, the covered entity (in the Center of Excellence for Research in Complementary and Alternative Medicine study, chiropractic clinics) must obtain documentation of the study's approval from the organizational IRB. The documentation must contain the following 5 elements:
1. "Identification of the IRB or Privacy Board and the date on which the alteration or waiver of authorization was approved; 2. The statement that the IRB or Privacy Board has determined that the alteration or waiver of authorization, in whole or in part, satisfies the 3 criteria in the Rule; 3. A brief description of the protected health information for which use or access has been determined to be necessary by the IRB or Privacy Board; 4. A statement that the alteration or waiver of authorization has been reviewed and approved under either normal or expedited review procedures; and 5. The signature of the chair or other member, as designated by the chair, of the IRB or the Privacy Board, as applicable." 10 We provided a copy of the HSPC approval letter to participating clinics. For clinics that expressed concern about HIPAA compliance, we also provided a document that explained, using clear and nonlegal language, our justification for not obtaining informed consent from the randomly sampled patients (see Appendix).
In addition, we offered to make the Data Safeguarding Plan (DSP) referenced in Figure 1 available to participating clinics who wished to view it. The extensive DSP details how we protected hard-copy and electronic data for all components of the study. Beyond the sections that are commonly included in DSPs at RAND, such as a description of the study, which study team members are responsible for safeguarding the data, and the level of sensitivity of the data, our plan also includes a table with rows for every data collection component (eg, hard-copy consent forms from pilot study, digital audio recordings of exploratory interviews, electronic survey data, electronic scans of chiropractic records), and columns where we specified whether or not that component of data contained personal identifiers, how the data will be collected and transferred to our office, how data will be stored, and when and how data will be destroyed at the end of the study. The DSP also included appendices for other relevant documents, such as a nondisclosure agreement signed by a subcontractor institution who implemented the national surveys.
We also should note that any violations of our data safeguarding protocols, whether they were committed by our own staff or by clinic staff in the process of transferring files to us, were reported to our HSPC.
Before obtaining charts from clinics, we conducted a thorough orientation call with doctors of chiropractic and their clinic staff during which we explained the process and assessed which would be the best chart pull technique to use with their clinic based on how they stored their charts and their schedule. We provided the clinic staff written instructions on how to select and transfer patient charts for the study. Further, we provided the memo (see Appendix) to ensure that clinics abided by our data safeguarding protocols when transferring patient names or chart information to us.
DISCUSSION
By using this comprehensive approach to address the HIPAA concerns associated with collecting patient files, we have been largely successful. Using these protocols, 90 of the 125 study clinics provided patient files for the study. Of the 90 clinics, only 3 refused to provide patient files for the random sample. This highlights that most of those who gave patient chart data at all also gave us patient chart data for the random sample.
It is imperative to the profession that practitioners who employ manipulation and mobilization, and the individuals leading the professions' educational programs and advising clinics on HIPAA regulations, are well versed on the rules for conducting research that involve patient data collection. All practitioners must understand that adhering to HIPAA regulations is not a barrier to research participation; if fact, these laws allow for the collection of such patient data provided certain safeguards are in place. With this paper, we have explained the stipulations under which the HIPAA Privacy Rule allows for use of identified patient information without prior patient authorization and demonstrated the steps taken in our current study to comply with these regulations. It is our hope that in providing this information, practitioners will continue to participate in studies that require the release of protected patient information because they may ultimately benefit both the patients and the professions. We must add that HIPAA does not replace or in any way diminish the obligations of going through a full IRB review. All the protocols shared here and described here also were reviewed by the human protection committee at RAND. The Health Insurance Portability and Accountability Act adds another layer of protection to participants that must be followed by those conducting research, albeit while allowing the research to occur. Charts cannot be obtained for research without having an IRB review. It meets the 2 requirements for all IRB reviews: it is research and it is on humans. There is an expanding literature base on HIPAA that deals with the rules and regulations, what is covered, and what is not. [11] [12] [13] For further detail about HIPAA and a waiver of patient authorization for identifiable patient health information, [8] [9] [10] please visit: https://www.hhs.gov/hipaa/for-professionals/ special-topics/research/index.html?language=es.
Limitations
Information about HIPAA applies in the United States, although other countries do have similar rules regarding protection of the patient's privacy. The approach adopted here was developed specifically for RAND and for this particular research project, so it may be limited in other applications. Other projects should adapt this method or use other methods to confront different problems, but the general principles should be the same.
CONCLUSION
For this study, we provided clinics with information about what the rules are under HIPAA, demonstrated how the study complied with those rules, explained the logic behind the necessity for collecting files from both the prospective and retrospective samples, and if requested, provided clinics with a confidentiality agreement signed by the study principal investigator and an organizational contracts representative. We hope that the process we developed will assist other CIH researchers and practitioners in future studies. 
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Practical Applications
• The paper contains information for CIH researchers who might wish to conduct practice-based research.
• This information also is helpful to chiropractic practitioners who might want, or be asked, to participate in research and must know what the HIPAA rules are for research.
